Fangzhou Inc. showcased its AI-powered chronic disease management solution developed with Tencent Health at the 2026 Tencent Cloud AI Industry Applications Summit. The solution integrates AI to support patients with personalized care and physicians with administrative tasks, aiming to improve long-term health outcomes and service efficiency. Built on Fangzhou's proprietary language model and Tencent's technology infrastructure, this collaboration enhances healthcare access and continuous management beyond one-time consultations. Fangzhou plans to expand this AI-driven approach to transform chronic disease care in China.
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
ARCpoint Inc. announced it will likely miss the July 29, 2026 deadline to file its annual financial statements and related reports due to a lack of funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and awaits ap...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...
Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
